Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II

BACKGROUND: The optimum diagnostic test method for Clostridioides difficile infection (CDI) remains controversial due to variation in accuracy in identifying true CDI. This post hoc analysis examined the impact of CDI diagnostic testing methodology on efficacy outcomes in phase 3 MODIFY I/II trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Wilcox, Mark H, Rahav, Galia, Dubberke, Erik R, Gabryelski, Lori, Davies, Kerrie, Berry, Claire, Eves, Karen, Ellison, Misoo C, Guris, Dalya, Dorr, Mary Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677672/
https://www.ncbi.nlm.nih.gov/pubmed/31375837
http://dx.doi.org/10.1093/ofid/ofz293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677672/
https://www.ncbi.nlm.nih.gov/pubmed/31375837
http://dx.doi.org/10.1093/ofid/ofz293

Ejemplares similares